PLRX Q4 2021 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$82M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-55.2% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$25M-1230.6% margin

Net Income

-$25M-1227.2% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

+24.2%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$221M

Total Liabilities

$22M

Stockholders' Equity

$199M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-55.2%
Gross Profit	$2M	$4M	-55.2%
Operating Income	-$25M	-$19M	-29.4%
Net Income	-$25M	-$19M	-28.9%